WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115421) USE OF A COMPOUND COMPRISING D-MANNOHEPTULOSE AND/OR PERSEITOL FOR TREATING AND PREVENTING INNATE IMMUNITY MODIFICATION DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115421    International Application No.:    PCT/FR2005/001075
Publication Date: 08.12.2005 International Filing Date: 29.04.2005
IPC:
A23L 1/29 (2006.01), A23L 1/30 (2006.01), A61K 31/7004 (2006.01), A61K 36/48 (2006.01), A61K 8/60 (2006.01), A61K 8/97 (2006.01), A61Q 19/00 (2006.01)
Applicants: LABORATOIRES EXPANSCIENCE [FR/FR]; 10, avenue de l'Arche, F-92400 Courbevoie (FR) (For All Designated States Except US).
PICCIRILLI, Antoine [FR/FR]; (FR) (For US Only).
PICCARDI, Nathalie [FR/FR]; (FR) (For US Only).
MSIKA, Philippe [FR/FR]; (FR) (For US Only).
PAUL, François [FR/FR]; (FR) (For US Only).
BREDIF, Stéphanie [FR/FR]; (FR) (For US Only)
Inventors: PICCIRILLI, Antoine; (FR).
PICCARDI, Nathalie; (FR).
MSIKA, Philippe; (FR).
PAUL, François; (FR).
BREDIF, Stéphanie; (FR)
Agent: MARTIN, Jean-Jacques; Cabinet Regimbeau, 20, rue de Chazelles, F-75847 Paris Cedex 17 (FR)
Priority Data:
0404635 30.04.2004 FR
Title (EN) USE OF A COMPOUND COMPRISING D-MANNOHEPTULOSE AND/OR PERSEITOL FOR TREATING AND PREVENTING INNATE IMMUNITY MODIFICATION DISEASES
(FR) UTILISATION D’UNE COMPOSITION COMPRENANT DU D-MANNOHEPTULOSE ET/OU DU PERSEITOL DANS LE TRAITEMENT ET LA PREVENTION DES MALADIES LIEES A UNE MODIFICATION DE L’IMMUNITE INNEE
Abstract: front page image
(EN)The invention relates to the use of a compound comprising D-mannoheptulose and/ or perseitol for producing a drug for treating and/or preventing diseases related to the modification of an innate and/or acquired immunity by increasing the production of antimicrobial peptides, preferably hBD-2 without inducing inflammatory reactions, irritation or intolerance. Said compound can also comprise a peptidic avocado extract an/or a peptidic lupin extract.
(FR)La présente invention concerne l'utilisation d'une composition comprenant du D­mannoheptulose et/ou du perséitol pour la fabrication d'un médicament destiné au traitement et/ou à la prévention de maladies liées à une modification de l'immunité innée et/ou acquise, via l'augmentation de la production de peptides antimicrobiens, avantageusement de la hBD-2, sans induire de réactions inflammatoires, d'irritations ou d'intolérances. La composition peut en outre comprendre un extrait peptidique d'avocat et/ou un extrait peptidique de lupin.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)